STARgraft -Synthetic Vascular Graft

Healionics is commercializing a synthetic vascular graft (STARgraft) with superior patency (ability to maintain blood flow), based on our platform STAR biomaterial technology.  The graft will initially address the urgent need for improved vascular access for hemodialysis patients, with subsequent applications to peripheral artery disease, vascular trauma, and potentially coronary artery bypass. We are also developing a device to enable needle-free hemodialysis (STARport).